๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy

โœ Scribed by Charles H. Nash III; Stephen E. Jones; Thomas E. Moon; Steward L. Davis; Sydney E. Salmon

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
711 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy for metastatic
Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate
โœ Ambrose Aboud; Aman U. Buzdar; Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. B ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 270 KB

Twenty-nine patients with metastatic breast cancer were treated with fluorouracil, adriamycin, cyclophosphamide (FAC), and methotrexate (MTX), with or without leukovorin rescue. Of 24 evaluable patients, one achieved a complete remission and 17 had partial responses. The overall objective response r

Combination chemoimmunotherapy of metast
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG
โœ Gabriel N. Hortobagyi; Jordan U. Gutterman; George R. Blumenschein; Charles K. T ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 619 KB

One hundred five patients with metastatic breast cancer were treated with 5-fluorouracil, Adriamycin, cyclophosphamide and BCG (FAC-BCG). The results were compared to those observed in a group of 44 patients treated with FAC chemotherapy alone. Although the overall response rates were similar (76% f